Skip to main content
Hatem Soliman, MD, Oncology, Tampa, FL

Hatem H Soliman MD

Oncology•Tampa, FL

Breast Cancer

Senior Member Breast and Immunology Departments Medical Director, Clinical Trials Office H. Lee Moffitt Cancer Center and Research Institute Senior Professor Department of Oncologic Sciences University of South Florida

Request appointment

  • 12902 USF Magnolia DrTampa, FL 33612

  • Book by Phone+1(754) 663-3294

Overview of  Dr. Soliman

Dr. Hatem Soliman is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from Medical College of Georgia at Augusta University and has been in practice 24 years. Dr. Soliman accepts several types of health insurance, listed below. He is one of 203 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 100 publications and over 500 citings.

Education & Training

  • University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General Hospital
    University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General HospitalFellowship, Hematology and Medical Oncology, 2005 - 2008
  • University of South Florida Morsani
    University of South Florida MorsaniResidency, Internal Medicine, 2002 - 2005
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 2002
  • University of Georgia Athens
    University of Georgia AthensBS, 1996

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2004 - 2027
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2014, 2016
  • CMS Meaningful Use Stage 1 Certification PathNet, Cerner Corporation, 2014, 2016
  • CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2014, 2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry  
    Soliman H, Rawal B, Fulp J, Lee JH, Lopez A, Bui MM, Khalil F, Antonia S, Yfantis HG, Lee DH, Dorsey TH, Ambs S, Cancer Immunol Immunother., 1/1/2013
  • Indoleamine 2,3-dioxygenase: is it an immune suppressor?  
    Soliman H, Mediavilla-Varela M, Antonia S., Cancer J., 1/1/2010
  • A GM-CSF and CD40L bystander vaccine is effective in a murine breast cancer model  
    Soliman H, Mediavilla-Varela M, Antonia SJ, Breast Cancer (Dove Med Press)., 1/15/2015

Abstracts/Posters

  • A phase 1/2 study of Ad.p53 DC vaccine with indoximod immunotherapy in metastatic breast cancer.
    Soliman H, Minton S, Ismail-Khan R, Han H, Vahanian N, Link C, Kennedy G, Streicher H, Sullivan D, Antonia S, San Antonio Breast Cancer Symposium, San Antonio, TX, 1/1/2014
  • A phase 1 study of ad.p53 DC vaccine in combination with indoximod in metastatic solid tumors.
    Soliman H, Minton S, Han H, Ismail-Khan R, Mahipal A, Janssen W, Streicher H, Vahanian N, Link C, Ramsey W, Antonia S, Sullivan D, J Clin Oncol, ASCO Annual Meeting, Chicago, IL, 1/1/2013
  • Combination immunotherapy with PD-L1 blockade and Poly I:C in a murine breast cancer model.
    Hatem Soliman, Ashley R. Nelson., Proceedings of the 105th Annual Meeting of the American Association for Cancer Research, AACR, Cancer Res, San Diego, CA, 2014; Philadelphia, PA, 2014, 1/5./2014

Lectures

  • In silico evaluation of the 12-gene molecular score (EndoPredict) and the recurrence score (Oncotype DX) as predictors of response to neo-adjuvant chemotherapy in estr... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Vaccine Enhances Chemotherapy Response in HER2+ Breast Cancer
    Vaccine Enhances Chemotherapy Response in HER2+ Breast CancerMarch 20th, 2025
  • Vaccine May Improve Breast Cancer Treatment Outcomes
    Vaccine May Improve Breast Cancer Treatment OutcomesMarch 18th, 2025
  • Moffitt Research Reveals Potential of Vaccine to Enhance Breast Cancer Treatment Efficacy
    Moffitt Research Reveals Potential of Vaccine to Enhance Breast Cancer Treatment EfficacyMarch 18th, 2025

Professional Memberships

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    AvMed Health Open Access
    BCBS Blue Card PPO
    BCBS Florida BlueCare HMO
    BCBS Florida NetworkBlue
    BCBS Florida Preferred Patient Care PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Coventry Florida - Employer Group PPO
    First Health PPO
    Great West PPO
    HIP of New York - Select PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Hatem Soliman, Dr. Hatem Soliman, MD, Dr. H Soliman, Dr. Hatem H Soliman